BPA Call 36E79720A0007-36C25220N0295
Award Date
4/1/20
Potential Completion Date
4/10/20
Potential Value
$10K
Federal Agency
Veterans Integrated Service Network 12
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15275, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Otsuka America Pharmaceutical Inc. has been awarded a $12,580.72 delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to provide tolvaptan. The order was issued against Otsuka's Federal Supply Schedule contract for Pharmaceuticals and Drugs under schedule number FSS-61-IB, with performance taking place in Potomac, Maryland. The contract type is firm fixed price and there is no set-aside designation. Otsuka holds two major...
Otsuka America Pharmaceutical Inc. was awarded a firm fixed price blanket purchase agreement call against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1. The contract has a potential value of $30,103.89 to deliver tolvaptan, a drug used to treat hyponatremia, with performance required by September 30, 2020 in Chelsea, Maine. No set-aside designation was applied to this award made...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a $297,067.94 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule to Otsuka America Pharmaceutical Inc. The firm fixed price order is for the provision of Tolvaptan (Jynarque), a medication for direct patient care, with performance at a location in Potomac, Maryland. Delivery is required by September 30, 2022. No set-aside designation was applied to this order...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a delivery order to Otsuka America Pharmaceutical Inc., a for-profit manufacturer of pharmaceuticals, for the supply of the drug TOLVAPTAN (JYNARQUE) for the treatment of kidney disorders. The $102,766.58 firm-fixed price order was issued under Otsuka's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), without any set-aside designations. Otsuka has held multiple VA delivery orders...
The Department of Veterans Affairs Veterans Health Administration awarded a $12,195.72 firm fixed price delivery order against GSA Schedule Pharmaceuticals and Drugs (FSS-61-IB) to Otsuka America Pharmaceutical Inc. The order is for the drug JYNARQUE 90MG-30MG and has a period of performance from September 19-22, 2023 in Pittsburgh, Pennsylvania. GSA Schedule FSS-61-IB provides federal agencies access to pharmaceutical products and drugs to support the VA's mission of providing quality...
Otsuka America Pharmaceutical Inc. was awarded a $12,195.72 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order, which contains no set-aside designation and must be completed by May 16, 2023, is for the purchase of JYNARQUE 90MG-30MG. Place of performance will be in Pittsburgh, Pennsylvania. This delivery order was issued under Otsuka...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 has awarded a $155,724.16 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract to Otsuka America Pharmaceutical Inc. to supply tolvaptan (Jynarque) through Alliancerx Walgreens Specialty Pharmacy as the sole distributor. The sole source procurement is to fulfill a request from VA San Diego Pharmacy Service and will provide the drug through September 2023. As...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded Otsuka America Pharmaceutical Inc. a $12,195.72 firm fixed price delivery order against the company's Pharmaceuticals and Drugs GSA Schedule contract. The order is for JYNARQUE 90MG-30MG and will be performed from December 12-15, 2023 in Pittsburgh, Pennsylvania. Otsuka America Pharmaceutical will deliver the requested pharmaceutical products to VA-VHA under the master agreement, which...
Otsuka America Pharmaceutical Inc. was awarded an $11,413.72 delivery order against the Pharmaceuticals and Drugs (FSS-61-IB) master contract vehicle by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6. The firm fixed price order, which does not have a set-aside designation, is for the delivery of medications to the agency's Potomac, Maryland location and must be completed by August 31, 2022. The master contract facilitates the Veterans...
The Department of Veterans Affairs Veterans Health Administration awarded Otsuka America Pharmaceutical Inc. a $12,195.72 firm fixed price delivery order against the company's Pharmaceuticals and Drugs GSA Schedule contract. The order is for JYNARQUE 90MG/30MG to be delivered to a VA facility located in Pittsburgh, Pennsylvania between August 5-11, 2023. Otsuka America Pharmaceutical will provide the requested pharmaceutical products to the VA's Veterans Integrated Service Network 5 under this...